Abstract
A tight regulation of the neuroparenchymal microenvironment is imperative for proper neurological function. The flux of blood-borne ions and solutes is restricted by specialized tissue barriers and of the three main central nervous system barriers, the brain endothelium constituting the blood-brain barrier represents the major interface between blood and brain. At the basis of the bloodbrain barrier are, next to an elaborate transporting machinery, tight junctions which create not only a paracellular diffusion constraint but also enable vectorial transport across the endothelial monolayer. Generally, tight junctions not only represent a cellcell adhesion structure, but integrate various signaling pathways via large multiprotein complexes, thereby impacting upon processes such as cell proliferation, cytoskeletal rearrangement, and transcriptional control. This review provides an overview of tight junction morphology and discusses our current understanding of the molecular composition of endothelial tight junctions at the blood-brain barrier.
Keywords: Blood-brain barrier, tight junctions, scaffold proteins, zonula occludens, brain capillary endothelial cells, vascular permeability.
CNS & Neurological Disorders - Drug Targets
Title:Tight Junctions of the Blood-Brain Barrier – A Molecular Gatekeeper
Volume: 15 Issue: 9
Author(s): Hannelore Bauer and Andreas Traweger
Affiliation:
Keywords: Blood-brain barrier, tight junctions, scaffold proteins, zonula occludens, brain capillary endothelial cells, vascular permeability.
Abstract: A tight regulation of the neuroparenchymal microenvironment is imperative for proper neurological function. The flux of blood-borne ions and solutes is restricted by specialized tissue barriers and of the three main central nervous system barriers, the brain endothelium constituting the blood-brain barrier represents the major interface between blood and brain. At the basis of the bloodbrain barrier are, next to an elaborate transporting machinery, tight junctions which create not only a paracellular diffusion constraint but also enable vectorial transport across the endothelial monolayer. Generally, tight junctions not only represent a cellcell adhesion structure, but integrate various signaling pathways via large multiprotein complexes, thereby impacting upon processes such as cell proliferation, cytoskeletal rearrangement, and transcriptional control. This review provides an overview of tight junction morphology and discusses our current understanding of the molecular composition of endothelial tight junctions at the blood-brain barrier.
Export Options
About this article
Cite this article as:
Bauer Hannelore and Traweger Andreas, Tight Junctions of the Blood-Brain Barrier – A Molecular Gatekeeper, CNS & Neurological Disorders - Drug Targets 2016; 15 (9) . https://dx.doi.org/10.2174/1871527315666160915142244
DOI https://dx.doi.org/10.2174/1871527315666160915142244 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Mechanism Aspect of ER Stress in Alzheimer's Disease: Current Approaches and Future Strategies
Current Drug Targets Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Recent Advance of Computational Approaches in Genomics and Proteomics
Current Bioinformatics Exploration of Umbelliferone Based Derivatives as Potent MAO Inhibitors: Dry vs. Wet Lab Evaluation
Current Topics in Medicinal Chemistry Advances in Chagas Disease Chemotherapy
Anti-Infective Agents in Medicinal Chemistry Hydrogen Sulfide: A New Tool to Design and Develop Drugs
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease
Current Drug Targets The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Current Cancer Drug Targets Modulation of Cytokine Network in the Comorbidity of Schizophrenia and Tuberculosis
Current Topics in Medicinal Chemistry A Comparative Study between Lithium and Extended-release Carbamazepine in Acute Mania: A Double-blind Clinical Trial
Current Psychopharmacology Histomorphometric Analysis of Salivary Gland in Wistar Rats Treated Chronically With Two Benzodiazepines
Current Pharmaceutical Biotechnology Conduction Disorders: The Value of Surface ECG
Current Cardiology Reviews Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex
Current Pharmaceutical Design Endogenous Opioids and Addiction to Alcohol and other Drugs of Abuse
Current Topics in Medicinal Chemistry High Resolution Nuclear Magnetic Resonance Spectroscopy on Biological Tissue and Metabolomics
Current Medicinal Chemistry Synthesis and Biological Activities of Sulfinyl Acetamide Derivatives for Narcolepsy Treatment
Letters in Drug Design & Discovery Iron Chelators in Cancer Chemotherapy
Current Topics in Medicinal Chemistry Hypofractionated Radiotherapy in Non Small Cell Lung Cancer: A Review of the Current Literature
Reviews on Recent Clinical Trials Meet Our Editorial Board Member
Current Organic Synthesis Oxytocin as a Potential Adjuvant Against COVID-19 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets